AbCellera Biologics EPS Diluted (Quarterly) Insights

AbCellera Biologics Inc (ABCL)

2.715 -0.16 (-5.73%) USD | NASDAQ | Nov 05, 16:00

2.715 0.00 (0.00%) After-Hours: 18:51

EPS Diluted (Quarterly) Chart

Historical EPS Diluted (Quarterly) Data

View and export this data back to 2019. Upgrade now.

Date	Value
June 30, 2024	-0.13
March 31, 2024	-0.14
December 31, 2023	-0.17
September 30, 2023	-0.10
June 30, 2023	-0.11
March 31, 2023	-0.14
December 31, 2022	-0.10
September 30, 2022	0.08
June 30, 2022	-0.02
March 31, 2022	0.54

Date	Value
December 31, 2021	0.19
September 30, 2021	-0.08
June 30, 2021	-0.01
March 31, 2021	0.37
December 31, 2020	0.3107
September 30, 2020	-0.0101
June 30, 2020	0.0282
March 31, 2020	-0.0097
December 31, 2019	-0.0076

Earnings per Share Definition

Earnings per share measures the total net income / average shares outstanding during income period. There are a few variations to earnings per share that are listed including "EPS Basic", "EPS Diluted", "Normalized Basic EPS", and "Normalized Diluted EPS". Each of these metrics are dependent on which earnings and shares outstanding metrics are used. Basic and Diluted EPS differ in that diluted shares are the amount of shares outstanding after all convertible securities, options, and warrants are exercised. Normalized EPS allows does not include one-time expenses.

Read full definition.

EPS Diluted (Quarterly) Range, Past 5 Years

-0.17

Minimum

Dec 2023

0.54

Maximum

Mar 2022

0.0259

Average

-0.0101

Median

Sep 2020

EPS Diluted (Quarterly) Benchmarks

Grace Therapeutics Inc	-0.24
Aurinia Pharmaceuticals Inc	0.01
Edesa Biotech Inc	-0.52
Lexaria Bioscience Corp	-0.13
InMed Pharmaceuticals Inc	-0.19

EPS Diluted (Quarterly) Related Metrics

Net Income (Quarterly)	-36.93M
Revenue (Quarterly)	7.323M
Total Expenses (Quarterly)	97.47M
Enterprise Value	178.28M
Profit Margin (Quarterly)	-504.3%
Earnings Yield	-19.89%
Normalized Earnings Yield	-19.89